A retrospective single center study was performed on 516 trephine biopsies derived from
160 patients with stable phase Ph+-CML and allogeneic BMT. Following morphometric …

Allogeneic haematopoietic cell transplantation (allo-HCT) remains the only curative
approach in myelofibrosis (MF). Despite advances over recent decades, relapse and non …

Allogeneic hematopoietic stem cell transplantation is curative in myelofibrosis, and current
prognostic scoring systems aim to select patients for transplantation. Here, we aimed to …

We performed a retrospective assessment of patient-and transplant-specific characteristics
and outcomes for 4142 patients undergoing allogeneic haematopoietic cell transplant for …

Allogeneic stem cell transplantation remains the only curative therapy for myelofibrosis.
Despite advances in transplant, the morbidity and the mortality of the procedure necessitate …

Allogeneic stem cell transplantation is a curative therapy for myelofibrosis. The optimal
conditioning regimen has not been well defined. We retrospectively compared …

The number of patients with myelofibrosis (MF) undergoing an allogeneic hemopoietic stem
cell transplantation (HSCT) is increasing: in the analysis of the European Group for Blood …

Myeloproliferative neoplasm (MPN) is a category in the World Health Organization
classification of myeloid tumors. BCR-ABL1–negative MPN is a subcategory that includes …

We screened 136 patients with myelofibrosis and a median age of 58 years who underwent
allogeneic stem cell transplantation (AHSCT) for molecular residual disease for JAKV617F …

Background: Primary and secondary [post-essential thrombocythemia (ET) or polycythemia
vera (PV)] Myelofibrosis (MF) are clonal hematopoietic neoplasms marked by constitutive …